To include your compound in the COVID-19 Resource Center, submit it here.

FDA accepts NDA for ulipristal from Allergan for uterine bleeding

Allergan plc (NYSE:AGN) said FDA accepted for review an NDA for ulipristal

Read the full 127 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE